Anesthetic drugs and bariatric surgery

Expert Review of Neurotherapeutics

Volumn 6, Issue 7, 2006, Pages 1107-1113

  Lemmens, Hendrikus J M ^a   Brodsky, Jay B ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Body mass index; Dosage; Ideal body weight; Lean body weight; Morbid obesity; Obesity; Pharmacodynamics; Pharmacokinetics

Indexed keywords

ANESTHETIC AGENT; DESFLURANE; ISOFLURANE; MUSCLE RELAXANT AGENT; OPIATE; PROPOFOL; REMIFENTANIL; ROCURONIUM; SEVOFLURANE; SUXAMETHONIUM; VECURONIUM;

ANESTHESIA INDUCTION; BARIATRIC SURGERY; BODY MASS; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG METABOLISM; HUMAN; OBESITY; REVIEW;

ANESTHETICS; BARIATRIC SURGERY; BODY WEIGHT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; HUMANS; OBESITY, MORBID; PAIN, POSTOPERATIVE; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; TREATMENT OUTCOME;

EID: 33745955210     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/14737175.6.7.1107     Document Type: Review

References (59)

1. Cheymol G. Effects of obesity on pharmacokinetics implications for drug therapy. Clin. Pharmacokinet. 39(3), 215-231 (2000).
2. Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA 291(10), 1238-1245 (2004).
3. Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Correction: actual causes of death in the United States 2000. JAMA 293(3), 293-294 (2005).
4. No authors listed. Gastrointestinal surgery for severe obesity. Consens Statement 9(1), 1-20 (1991).
5. Lemmens HJ, Brodsky JB, Bernstein DP. Estimating ideal body weight - a new formula. Obes. Surg. 15(7), 1082-1083 (2005).
6. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37(12), 1595-1607 (1988).
7. Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the US. Diabetes Care 28(11), 2745-2749 (2005).
8. Malik S, Wong ND, Franklin SS et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 110(10), 1245-1250 (2004).
9. Alexander JK, Dennis EW, Smith WG et al. Blood volume, cardiac output, and distribution of systemic blood flow in extreme obesity. Cardiovasc. Res. Cent. Bull. 1, 39-44 (1962).
10. Alpert MA. Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome. Am. J. Med. Sci. 321(4), 225-236 (2001).
11. Koenig SM. Pulmonary complications of obesity. Am. J. Med. Sci. 321(4), 249-279 (2001).
12. Sampson MG, Grassino K. Neuromechanical properties in obese patients during carbon dioxide rebreathing. Am. J. Med. 75(1), 81-90 (1983).
13. Pelosi P, Croci M, Ravagnan I, Vicardi P, Gattinoni L. Total respiratory system, lung, and chest wall mechanics in sedated-paralyzed postoperative morbidly obese patients. Chest 109(1), 144-151 (1996).
14. Yap JC, Watson RA, Gilbey S, Pride NB. Effects of posture on respiratory mechanics in obesity. J. Appl. Physiol. 79(4), 1199-1205 (1995).
15. Gilbert R, Sipple JH, Auchincloss JH Jr. Respiratory control and work of breathing in obese subjects. J. Appl. Physiol. 16, 21-26 (1961).
16. Jenkins SC, Moxham J. The effects of mild obesity on lung function. Respir. Med. 85(4), 309-311 (1991).
17. Ray CS, Sue DY, Bray G, Hansen JE, Wasserman K. Effects of obesity on respiratory function. Am. Rev. Respir. Dis. 128(3), 501-506 (1983).
18. Kronenberg RS, Gabel RA, Severinghaus JW. Normal chemoreceptor function in obesity before and after ileal bypass surgery to force weight reduction. Am. J. Med. 59(3), 349-353 (1975).
19. Burki NK, Baker RW. Ventilatory regulation in eucapnic morbid obesity. Am. Rev. Respir. Dis. 129(4), 538-543 (1984).
20. Zwillich CW, Sutton FD, Pierson DJ, Greagh EM, Weil JV. Decreased hypoxic ventilatory drive in the obesity-hypoventilation syndrome. Am. J. Med. 59(3), 343-348 (1975).
21. Barrera F, Reidenberg MM, Winters WL, Hungspreugs S. Ventilation- perfusion relationships in the obese patient. J. Appl. Physiol. 26(4), 420-426 (1969).
22. Barrera F, Hillyer P, Ascanio G, Bechtel J. The distribution of ventilation, diffusion, and blood flow in obese patients with normal and abnormal blood gases. Am. Rev. Respir. Dis. 108(4), 819-830 (1973).
23. Burwell CS, Robin ED, Whaley RD, Bickelmann AG. Extreme obesity associated with alveolar hypoventilation - a Pickwickian Syndrome, 1956. Obes. Res. 2(4), 390-397 (1994).
24. Katz I, Stradling J, Slutsky AS, Zamel N, Hoffstein V. Do patients with obstructive sleep apnea have thick necks? Am. Rev. Respir. Dis. 141(5 Pt 1), 1228-1231 (1990).
25. Partinen M, Guilleminault C. Daytime sleepiness and vascular morbidity at seven-year follow-up in obstructive sleep apnea patients. Chest 97(1), 27-32 (1990).
26. He J, Kryger MH, Zorick FJ, Conway W, Roth T. Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients. Chest 94(1), 9-14 (1988).
27. Frey WC, Pilcher J. Obstructive sleep-related breathing disorders in patients evaluated for bariatric surgery. Obes. Surg. 13(5), 676-683 (2003).
28. O'Keeffe T, Patterson EJ. Evidence supporting routine polysomnography before bariatric surgery. Obes. Surg. 14(1), 23-26 (2004).
29. Gross JB, Bachenberg KL, Benumof JL et al. Practice guidelines for the perioperative management of patients with obstructive sleep apnea: a report by the American Society of Anesthesiologists Task Force on perioperative management of patients with obstructive sleep apnea. Anesthesiology 104(5), 1081-1093 (2006). Very up-to-date review of the perioperative anesthetic management of patients with obstructive sleep apnea.
30. Moretto M, Kupski C, Mottin CC et al. Hepatic steatosis in patients undergoing bariatric surgery and its relationship to body mass index and comorbidities. Obes. Surg. 13(4), 622-624 (2003).
31. Dixon JB, Schachter LM, O'Brien PE. Sleep disturbance and obesity: changes following surgically induced weight loss. Arch. Intern. Med. 161(1), 102-106 (2001).
32. Sjostrom L, Lindroos AK, Peltonen M et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N. Engl. J. Med. 351(26), 2683-2693 (2004).
33. Noel PH, Pugh JA. Management of overweight and obese adults. BMJ 325(7367), 757-761 (2002).
34. Nguyen NT, Root J, Zainabadi K et al. Accelerated growth of bariatric surgery with the introduction of minimally invasive surgery. Arch. Surg. 140(12), 1198-1202 (2005).
35. Dindo D, Muller MK, Weber M, Clavien PA. Obesity in general elective surgery. Lancet 361(9374), 2032-2035 (2003).
36. Dundee JW, Hassard TH, McGowan WA, Henshaw J. The 'induction' dose of thiopentone. A method of study and preliminary illustrative results. Anaesthesia 37(12), 1176-1184 (1982).
37. Bouillon T, Shafer SL. Does size matter? (Editorial views). Anesthesiology 89(5), 557-560 (1998). Editorial summarizes the potential differences in drug dosing based on weight. Concludes that size does matter.
38. Wada DR, Bjorkman S, Ebling WF et al. Computer simulation of the effects of alterations in blood flows and body composition on thiopental pharmacokinetics in humans. Anesthesiology 87(4), 884-899 (1997).
39. Jung D, Mayersohn M, Perrier D, Calkins J, Saunders R. Thiopental disposition in lean and obese patients undergoing surgery. Anesthesiology 56(4), 269-274 (1982).
40. Servin F, Farinotti R, Haberer JP, Desmonts JM. Propofol infusion for maintenance of anesthesia in morbidly obese patients receiving nitrous oxide. A clinical and pharmacokinetic study. Anesthesiology 78(4), 657-665 (1993). Propofol is probably the most commonly used anesthetic induction agent.
41. Kisor DF, Schmith VD. Clinical pharmacokinetics of cisatracurium besilate. Clin. Pharmacokinet. 36(1), 27-40 (1999).
42. Alvarez AO, Cascardo A, Albarracin Menendez S, Capria JJ, Cordero RA. Total intravenous anesthesia with midazolam, remifentanil, propofol and cistracurium in morbid obesity. Obes. Surg. 10(4), 353-360 (2000).
43. Leykin Y, Pellis T, Lucca M et al. The effects of cisatracurium on morbidly obese women. Anesth. Analg. 99(4), 1090-1094 (2004).
44. Kirkegaard-Nielsen H, Helbo-Hansen HS, Lindholm P, Severinsen IK, Pedersen HS. Anthropometric variables as predictors for duration of action of atracurium-induced neuromuscular block. Anesth. Analg. 83(5), 1076-1080 (1996).
45. Schwartz AE, Matteo RS, Ornstein E, Halevy JD, Diaz J. Pharmacokinetics and pharmacodynamics of vecuronium in the obese surgical patient. Anesth. Analg. 74(4), 515-518 (1992).
46. Leykin Y, Pellis T, Lucca M et al. The pharmacodynamic effects of rocuronium when dosed according to real body weight or ideal body weight in morbidly obese patients. Anesth. Analg. 99(4), 1086-1089 (2004).
47. Bentley JB, Borel JD, Vaughan RW, Gandolfi AJ. Weight, pseudocholinesterase activity, and succinylcholine requirement. Anesthesiology 57(1), 48-49 (1982).
48. Lemmens HJ, Brodsky JB. The dose of succinylcholine in morbid obesity. Anesth. Analg. 102(2), 438-442 (2006).
49. Shibutani K, Inchiosa MA Jr, Sawada K, Bairamian M. Accuracy of pharmacokinetic models for predicting plasma fentanyl concentrations in lean and obese surgical patients: derivation of dosing weight ("pharmacokinetic mass"). Anesthesiology 101(3), 603-613 (2004).
50. Slepchenko G, Simon N, Goubaux B et al. Performance of target-controlled sufentanil infusion in obese patients. Anesthesiology 98(1), 65-73 (2003).
51. Egan TD, Huizinga B, Gupta SK et al. Remifentanil pharmacokinetics in obese versus lean patients. Anesthesiology 89(3), 562-573 (1998).
52. Cork RC, Vaughan RW, Bentley JB. General anesthesia for morbidly obese patients - an examination of postoperative outcomes. Anesthesiology 54(4), 310-313 (1981).
53. Torri G, Casati A, Albertin A et al. Randomized comparison of isoflurane and sevoflurane for laparoscopic gastric banding in morbidly obese patients. J. Clin. Anesth. 13(8), 565-570 (2001).
54. Strum EM, Szenohradszki J, Kaufman WA et al. Emergence and recovery characteristics of desflurane versus sevoflurane in morbidly obese adult surgical patients: a prospective, randomized study. Anesth. Analg. 99(6), 1848-1853 (2004).
55. Arain SR, Barth CD, Shankar H, Ebert TJ. Choice of volatile anesthetic for the morbidly obese patient: sevoflurane or desflurane. J. Clin. Anesth. 17(6), 413-419 (2005). Demonstrates that there is essentially no difference in recovery time after general anesthesia with desflurane or sevoflurane.
56. Rigg JR, Jamrozik K, Myles PS et al. Epidural anaesthesia and analgesia and outcome of major surgery: a randomised trial. Lancet 359(9314), 1276-1282 (2002).
57. Schumann R, Shikora S, Weiss JM et al. A comparison of multimodal perioperative analgesia to epidural pain management after gastric bypass surgery. Anesth. Analg. 96(2), 469-474 (2003).
58. Schumann R, Jones SB, Ortiz VE et al. Best practice recommendations for anesthetic perioperative care and pain management in weight loss surgery. Obes. Res. 13(2), 254-266 (2005).
59. Ogunnaike BO, Jones SB, Jones DB, Provost D, Whitten CW. Anesthetic considerations for bariatric surgery. Anesth. Analg. 95(6), 1793-1805 (2002).